Spire Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.2K	Sell	200 -2	-1%	-$681	﹤0.01%	1094
2025 Q4	$80.3K	Sell	202 -5	-2%	-$2.21K	﹤0.01%	1050
2025 Q3	$94.3K	Buy	207 +2	+1%	+$814	﹤0.01%	1006
2025 Q2	$66.8K	Buy	205 +1	+0.5%	+$277	﹤0.01%	1110
2025 Q1	$55.1K	Sell	204 -1	-0.5%	-$257	﹤0.01%	1241
2024 Q4	$48.3K	Sell	205 -175	-46%	-$46K	﹤0.01%	1298
2024 Q3	$105K	Buy	380 +3	+0.8%	+$781	﹤0.01%	903
2024 Q2	$91.6K	Sell	377 -206	-35%	-$32.5K	﹤0.01%	917
2024 Q1	$87.1K	Buy	583 +3	+0.5%	+$500	﹤0.01%	1030
2023 Q4	$107K	Hold	580	–	–	﹤0.01%	980
2023 Q3	$103K	Sell	580 -1	-0.2%	-$191	﹤0.01%	942
2023 Q2	$110K	Sell	581 -315	-35%	-$62.5K	﹤0.01%	941
2023 Q1	$179K	Buy	896 +224	+33%	+$47.1K	0.01%	765
2022 Q4	$160K	Sell	672 -13	-2%	-$2.77K	0.01%	606
2022 Q3	$137K	Sell	685 -247	-27%	-$47.1K	0.01%	616
2022 Q2	$136K	Sell	932 -418	-31%	-$59.3K	0.01%	908
2022 Q1	$221K	Buy	1,350 +882	+188%	+$134K	0.01%	847
2021 Q4	$81K	Buy	468 +9	+2%	+$1.67K	﹤0.01%	1497
2021 Q3	$87K	Hold	459	–	–	﹤0.01%	1243
2021 Q2	$78K	Buy	459 +22	+5%	+$3.22K	﹤0.01%	1296
2021 Q1	$62K	Buy	+437	New	+$65.8K	﹤0.01%	1616